Of these applications, 75 have been reviewed while 45 have been rejected. Of those being reviewed, 30 applications were assessed to have met the VIFAP qualifying criteria, said Gan while delivering a Ministerial Statement.
VIFAP provides one-time goodwill financial assistance to those who experience serious side-effects linked to the COVID-19 vaccines administered in Singapore. Applications are open to citizens, permanent residents and long-term pass holders who have received their vaccination here. In his speech, Gan also noted that, as of 18 April, the Health Sciences Authority has received 2,796 reports of suspected adverse events related to vaccines administered in Singapore.
Can claim from the vaccines manufacturers hoh.....the left hand give out the handout the right hand take back.....problems solved.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.